Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/30354
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLee, Sze Ting-
dc.contributor.authorEmmett, Louise M-
dc.contributor.authorPattison, David A-
dc.contributor.authorHofman, Michael S-
dc.contributor.authorBailey, Dale L-
dc.contributor.authorLatter, Melissa J-
dc.contributor.authorFrancis, Roslyn J-
dc.contributor.authorScott, Andrew M-
dc.date2022-
dc.date.accessioned2022-06-23T00:38:22Z-
dc.date.available2022-06-23T00:38:22Z-
dc.date.issued2022-06-
dc.identifier.citationJournal of nuclear medicine : official publication, Society of Nuclear Medicine 2022; 63(6): 819-822en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/30354-
dc.description.abstractIn nuclear medicine, theranostics is a burgeoning development that is rapidly being implemented worldwide. There is an increasing need to provide a multidisciplinary framework to the practice of theranostics, ensuring that patients receive this treatment safely and are secure in the knowledge that their health-care practitioners are adequately trained. Nuclear medicine experts in Australia have taken the initiative of producing a set of theranostic guidelines relevant to Australian medical practice. These guidelines encompass specialist qualifications, patient care, radiopharmaceutical production, radiation safety, and dosimetry. We propose adaptation of these guidelines by other countries, and we promote standards of practice leading to optimal clinical outcomes for patients receiving theranostic treatments.en
dc.language.isoeng
dc.subjectgeneral oncologyen
dc.subjectguidelinesen
dc.subjectmolecular imagingen
dc.subjectradionuclide therapyen
dc.subjecttheranosticsen
dc.subjecttrainingen
dc.titleThe Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of nuclear medicine : official publication, Society of Nuclear Medicineen
dc.identifier.affiliationOlivia Newton-John Cancer Research Instituteen
dc.identifier.affiliationSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia..en
dc.identifier.affiliationDepartment of Nuclear Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia..en
dc.identifier.affiliationDepartment of Nuclear Medicine and Specialised PET Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia..en
dc.identifier.affiliationSchool of Medicine, University of Queensland, Brisbane, Queensland, Australia..en
dc.identifier.affiliationDepartment of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australiaen
dc.identifier.affiliationMedical School, University of Western Australia, Perth, Western Australia, Australia..en
dc.identifier.affiliationMolecular Imaging and Therapyen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Melbourne, Victoria, Australia..en
dc.identifier.affiliationSchool of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia..en
dc.identifier.affiliationDepartment of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia..en
dc.identifier.affiliationSt. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia..en
dc.identifier.affiliationMolecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia..en
dc.identifier.affiliationProstate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia..en
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/35393349/en
dc.identifier.doi10.2967/jnumed.122.263996en
dc.type.contentTexten
dc.identifier.orcid0000-0001-8641-456Xen
dc.identifier.orcid0000-0002-6656-295Xen
dc.identifier.pubmedid35393349
local.name.researcherLee, Sze Ting
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

44
checked on Nov 19, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.